We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
-18.58%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$736M
AUM Growth
-$206M
(-22%)
Cap. Flow
-$15M
Cap. Flow
% of AUM
-2.04%
Top 10 Holdings %
Top 10 Hldgs %
41.67%
Holding
172
New
4
Increased
40
Reduced
22
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$19.6M |
| 2 |
AERI
Aerie Pharmaceuticals
AERI
|
+$16.7M |
| 3 |
Gilead Sciences
GILD
|
+$11.1M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
+$10.5M |
| 5 |
CELG
Celgene Corp
CELG
|
+$8.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KTWO
K2M Group Holdings, Inc
KTWO
|
+$24.8M |
| 2 |
Johnson & Johnson
JNJ
|
+$16.9M |
| 3 |
Collegium Pharmaceutical
COLL
|
+$14.2M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$13M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 81.78% |
| 2 | Technology | 1.41% |
| 3 | Industrials | 1.2% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOLD
1
DELISTED
Amicus Therapeutics
FOLD
| $48.3M | 6.56% |
5,036,590
+169,300
| +3% | +$1.86M |
|
|
AERI
2
DELISTED
Aerie Pharmaceuticals
AERI
| $40.9M | 5.56% |
1,133,954
+356,484
| +46% | +$16.7M |
|
3
Alnylam Pharmaceuticals
ALNY
$35.7B
| $36.1M | 4.91% |
495,341
+111,300
| +29% | +$8.56M |
|
|
4
Teladoc Health
TDOC
$1.7B
| $31.3M | 4.26% |
632,075
+320,254
| +103% | +$19.6M |
|
|
ARRY
5
DELISTED
Array Biopharma Inc
ARRY
| $30.9M | 4.2% |
2,165,767
+71,600
| +3% | +$1.09M |
|
|
APLS
6
DELISTED
Apellis Pharmaceuticals
APLS
| $28.6M | 3.89% |
2,168,115
+129,599
| +6% | +$1.99M |
|
|
7
Gilead Sciences
GILD
$167B
| $26.6M | 3.61% |
424,890
+158,750
| +60% | +$11.1M |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $25.4M | 3.46% |
397,012
+116,000
| +41% | +$8.56M |
|
|
9
Collegium Pharmaceutical
COLL
$1.17B
| $19.9M | 2.7% |
1,156,934
-832,521
| -42% | -$14.2M |
|
|
IMMU
10
DELISTED
Immunomedics Inc
IMMU
| $18.6M | 2.52% |
1,301,305
+529,998
| +69% | +$10.5M |
|
11
Pfizer
PFE
$143B
| $18.6M | 2.52% |
448,294
-25,928
| -5% | -$1.08M |
|
12
Novartis
NVS
$293B
| $18.3M | 2.49% |
238,206
-15,289
| -6% | -$1.19M |
|
|
LJPC
13
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $16.6M | 2.26% |
1,759,171
+110,399
| +7% | +$1.66M |
|
|
PTLA
14
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $16.1M | 2.19% |
823,607
+79,000
| +11% | +$1.62M |
|
|
RARX
15
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $14.6M | 1.98% |
799,612
+450,900
| +129% | +$7.08M |
|
|
WMGI
16
DELISTED
Wright Medical Group Inc
WMGI
| $14.5M | 1.98% |
534,472
+86,900
| +19% | +$2.4M |
|
|
HRC
17
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $14.2M | 1.93% |
160,199
+26,862
| +20% | +$2.44M |
|
18
Bristol-Myers Squibb
BMY
$124B
| $13.4M | 1.82% |
257,197
+16,500
| +7% | +$887K |
|
19
Cigna
CI
$74.5B
| $12.7M | 1.73% |
67,119
+20,589
| +44% | +$4.3M |
|
20
Eli Lilly
LLY
$1.05T
| $12.1M | 1.64% |
104,166
+48,400
| +87% | +$5.41M |
|
21
Evolent Health
EVH
$654M
| $11.7M | 1.6% |
588,902
+24,699
| +4% | +$571K |
|
|
GBT
22
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $11.6M | 1.58% |
282,541
+44,500
| +19% | +$1.67M |
|
23
UnitedHealth
UNH
$387B
| $10.9M | 1.48% |
43,806
-13,999
| -24% | -$3.7M |
|
24
AtriCure
ATRC
$1.77B
| $10.9M | 1.48% |
355,728
+104,904
| +42% | +$3.27M |
|
25
Medtronic
MDT
$106B
| $10.7M | 1.45% |
117,451
-13,400
| -10% | -$1.25M |
|
Similar funds
RIP
CCM
LFWA
FWA
CF
WIM
MW
AFC
Sectoral Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, Sectoral Asset Management held 172 positions worth $736M, down 22% from $942M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Sectoral Asset Management's Q4 2018 filing shows 4 new, 40 increased, 22 reduced and 68 closed positions. Its largest new stake was Kineta, Inc. Common Stock: 11,298 shares worth $5.13M. The largest sale was K2M Group Holdings, Inc, an estimated $24.8M.
By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 85% a quarter earlier, followed by Technology and Industrials.
- Sectoral Asset Management's largest Q4 2018 buy was Kineta, Inc. Common Stock: 11,298 shares worth $5.13M.
- Sectoral Asset Management added most to Teladoc Health in Q4 2018, an estimated $19.6M increase.
- Sectoral Asset Management's biggest Q4 2018 reduction was Johnson & Johnson, cutting an estimated $16.9M.
- Sectoral Asset Management fully exited K2M Group Holdings, Inc in Q4 2018, selling an estimated $24.8M.
- Sectoral Asset Management's ten largest holdings make up 42% of its $736M portfolio in Q4 2018.
- Sectoral Asset Management opened 4 new positions and closed 68 in Q4 2018.
- Sectoral Asset Management's portfolio value fell 22% quarter-over-quarter to $736M.
Based on Sectoral Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.